期刊文献+

两种不同检测系统测定半胱氨酸蛋白酶抑制剂C的方法学评价 被引量:16

Evaluation of cystatin C with two kinds of detection systems
原文传递
导出
摘要 目的评估两种半胱氨酸蛋白酶抑制剂 C(Cystatin C,Cys C)检测系统的分析性能。方法 Cys C 分别采用 Dade Behring(德灵)公司出品的颗粒增强散射免疫比浊法(PENIA)和上海景源医疗器械有限公司出品的透射免疫比浊法试剂盒进行测定,评价的方法学指标为精密度、线性范围、抗干扰性、相关及偏倚。结果 Cys C 浓度在0.6~5.0 mg/L 时,两家试剂总变异系数(CV)<8%,检测线性范围为0.4~6mg/L。血红蛋白<10g/L,胆红素<300 mg/L,维生素 C<5 g/L 对两家试剂检测干扰<10%,在可接受范围内。甘油三酯(TG)≤20 mmol/L时德灵试剂检测不受影响(干扰<10%)。景源试剂 TG≥15 mmol/L 时低值血浆干扰>10%,高值血浆不受干扰。50份血样进行相关性分析的结果显示景源检测试剂盒与德灵的 PENIA 测定方法相关性良好(r=0.98,P<0.01)。线性回归分析经 Cusum 检验显示两方法间偏倚不具有统计学意义(P>0.05),但是景源测定结果较德灵结果偏低,平均偏倚为-0.16。对同一份样本景源与德灵测定 Cys C 的最小至最大偏差范围为1.1%~23%,平均为5.1%。结论两种方法的精密度、抗干扰性、线性范围符合要求,但是系统间测定结果存在一定偏差。 Objective To evaluate the performance of Cys C results among two detection system. Methods The particle-enhanced immunonephrometic assay was used in Dade Behring BNII. Immunoturbic assay was used in Hitachi 7170 to evaluate the JING' YUAN reagents. We compared the precison, linearity, interference, correlation, and calibrators agreement with Dade Behring BNII. Results The total CV of the samples that contain 0. 6 - 5.0 mg/L was less than 10%. The Dade Behring and JING'YUAN method showed good linearity. Haemoglobin ( 10 g/L), Bilirubin ( 300 mg/L) , Vitamin C(5 g/L) in the tested sample had no significant interference in the assay( interference 〈 10% ). The interference was no significant to Dade Behring when triglyceride ≤ 20 mmol/L. Triglycerides ( ≥ 15 mmol/L) has interference to JING'YUAN reagents. Results of method correlated well with that of the Dade Behring BNII PENIA (r =0. 98, P 〈0. 01). There have no significant deviation from linearity (P 〉0. 05) between JING' YUAN and Dade Behring reagents. Values were slightly lower than that from the Dade Behring BNII method, the mean bias was -0. 16. The bias range was 1.1% -23% between JING'YUAN and Dade Behring for one sample. Conclusions The precision, linearity and interference test were suitable for routine Cys C measurement on automated biochemistry analyzer, but results has bias.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2007年第11期1284-1287,共4页 Chinese Journal of Laboratory Medicine
关键词 半胱氨酸蛋白酶抑制剂 偏倚(流行病学) 试剂盒 Cysteine proteinase inhibitors Bias( Epidemiology ) Reagent kits
  • 相关文献

参考文献7

  • 1Dharnidharka VR, Kwon C, Stevens G. Serum Cys C is superior to serum creatinine as a marker of kidney function: a metaanalysis. Am J Kidney Dis, 2002,40:221-226.
  • 2Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum Cys C, determined by a rapid, automated particle-enhanced turbidimetrie method, is a better marker than serum ereatinine for glomerular filtration rate. Clin Chem, 1994, 40: 1921-1926.
  • 3Finney H, Newman DJ, Gruber W, et al. Initial evaluation of Cys C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems ( BNA, BNII ). Clin Chem, 1997, 43 : 1016-1022.
  • 4徐国宾,蒋琳.临床生物化学常规定量方法的分析性能评价[J].中华检验医学杂志,2007,30(6):718-720. 被引量:58
  • 5Erlandsen El, Banders E, Kristensen JH. Evaluation of the Dade Behring N Latex Cys C assay on the Dade Behring Nephelometer Ⅱ system. Scand J Clin Lab Invest,1999,59:1-8.
  • 6李海霞,张春丽,徐国宾,王学晶,李淑葵,李志艳,张旭初,夏铁安.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. 被引量:179
  • 7Uhlmann El, Hock KG, Issitt C, et al. Reference intervals for plasma Cys C in healthy volunteers and renal patients, as measured by the Dade Behring BN Ⅱ system, and correlation with creatinine. Clin Chem,2001,47 :2031-2033.

二级参考文献12

  • 1Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med, 1999,37:389-395.
  • 2Dharnidharka VR,Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function : a meta-analysis.Am J Kidney Dis,2002,40:221-226.
  • 3National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.Am J Kidney Dis,2002,39(2 Suppl 1 ) :S1-266.
  • 4Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Ann Intem Med, 1999,130:461-470.
  • 5Norlund L, Fex G, Lanke J, et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers : serum cystatin C and serum beta2-microglobulin/cystatin C ratio. Scand J Clin Lab Invest, 1997,57:463-470.
  • 6Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay : a more sensitive marker of changes in GFR than serum creatinine. Kidney Int, 1995,47 : 312-318.
  • 7Erlandsen E J, Randers E, Kristensen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med, 1998,36:393-397.
  • 8Uhlmann E J, Hock KG, Issitt C, et al. Reference intervals for plasma cystatin C in healthy volunteers and renal patients , as measured by the Dade Behring BN Ⅱ System ,and correlation with creatinine. Clin Chem, 2001,47 : 2031-2033.
  • 9Finney H,Newman DJ, Price CP. Adult reference for serum cystatin C,creatinine and predicted creatinine clearance. Ann Clin Biochem,2000,37:49-59.
  • 10Laterza OF,Price CP,Scott MG. Cystatin C :an improved estimator of glomerular filtration rate? Clin Chem ,2002,48:699-707.

共引文献235

同被引文献157

引证文献16

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部